Searched for
AJANTA PHARMA EARNINGS
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ajanta Pharma Q4 Results: Net profit soars 66% YoY to Rs 203 crRevenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta P...
- Ajanta Pharma Q4 Results: Net profit falls 5% to Rs 151 crFor the year ended March 31, 2022, the company posted a PAT of Rs 713 crore. It was Rs 654 crore in FY21. Revenue from operations rose to R...
- Ajanta Pharma Q3 Results: Net profit up 9% at Rs 192 croreDuring the period under review, the drug maker reported sales of Rs 256 crore in the domestic market, compared to Rs 220 crore earlier.
- Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
- Ajanta Pharma's reasonable valuations and other factors that make it this week's stock pickAjanta Pharma beat street expectations in the second quarter of 2020-21. However, it is still valued reasonably compared to other mid cap p...
- Buy Ajanta Pharma, target price Rs 1,880: EdelweissThe brokerage estimates earnings to expand at a 19% CAGR over FY20–22, led by 11% top-line CAGR and 250 bps margin expansion.
- Trending stocks: Ajanta Pharma share price jumps 5%A total of 28,668 shares changed hands on the counter till 11:05AM (IST).
- Motilal Oswal maintains 'buy' on Ajanta Pharma, target price Rs 1,655Shares of Ajanta Pharma ended down 1% at Rs 1,385.95 on Friday.
- HC allows Indian firm to export drug in which Bayer has patentBayer admitted before the court that it has not used its patents for commercial exploitation in India while Ajanta had launched its drug ba...
- Buy Ajanta Pharma Ltd., target Rs 2344.0 : Anand Rathihe brokerage expects annual sales of $15 million from Ajanta Pharma after the final approval.
- Buy Ajanta Pharma Ltd., target Rs 1784 : Anand RathiAnand Rathi cited Ajanta Pharma's sustained outperformance in the domestic formulations market and a healthy ANDA pipeline
- Ajanta Pharma Q4 net profit up 20% at Rs 84.31 croreAjanta Pharma reported 20 per cent rise in standalone net profit to Rs 84.31 crore for the quarter ended March 31, 2015 on robust sales.
- Expect decent upside for Ajanta Pharma over six-month horizon: Avinnash Gorakssakar, Miintdirect.comAvinnash Gorakssakar, Head of Research, Miintdirect.com, shares his views on Ajanta Pharma.
- Ajanta Pharma Q4 profit up 35% to Rs 23.59 croreAjanta Pharma today said its net profit rose by 35.10 per cent to Rs 23.59 crore for the fourth quarter ended March 31, 2012.
- Ajanta Pharma Q2 income up near 18 pc at Rs 11.85 croreDrug firm Ajanta Pharma today said its standalone net profit rose by 17.91 per cent to Rs 11.85 crore for the quarter ended September 30.
Load More
